NewLimit raised $435M in Series C funding led by Founders Fund to advance its first age-reprogramming drug into human trials.
Home / Brian Armstrong’s NewLimit Raises $435M for Human Trials
NewLimit raised $435M in Series C funding led by Founders Fund to advance its first age-reprogramming drug into human trials.
Shield Swap has announced a collaboration with Flowdesk to provide liquidity for institutional and professional traders while keeping their positions
Bitcoin enters the final weeks of October near $82,000 after a brief fall below $80,000. The October 28 Federal Reserve
Thai immigration police have arrested a 37-year-old Chinese man accused of exchanging cryptocurrency and foreign currency for a laundering network